MYDA Advisors’s Biomerica BMRA Stock Holding History

MYDA Advisors’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,222	Closed	-$138K	–	129
2023 Q1	$138K	Buy	+9,222	New	+$199K	0.05%	103

Other funds holding BMRA

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

HIMC

Heritage Investors Management Corp Bethesda, Maryland $3.29B AUM 26.44% 1-Year Est. Return

MYDA Advisors's BMRA Position: Q2 2023 in Review

MYDA Advisors sold out of Biomerica (BMRA) in Q2 2023, closing a stake of 9,222 shares — an estimated $138K sold.

MYDA Advisors first reported a position in BMRA in Q1 2023 and held it in 1 quarter. The position peaked at $138K in Q1 2023. 36 funds tracked by Wall St. Rank hold BMRA as of Q2 2023.

MYDA Advisors reported no remaining Biomerica position as of Q2 2023 after selling out during the quarter.
MYDA Advisors sold 9,222 Biomerica shares in Q2 2023, an estimated $138K.
MYDA Advisors first reported a position in Biomerica in Q1 2023 and held it in 1 quarter.
MYDA Advisors's Biomerica position peaked at $138K in Q1 2023.
36 funds tracked by Wall St. Rank held Biomerica as of Q2 2023.

Based on MYDA Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.